Home / CDMO solutions /
Aseptic fill finish
As one of the only CDMOs that can manage sterile fill, device manufacture and final assembly in a single location, we offer a unique combination of expertise, scale and geographic integration. From small-scale clinical batches to large commercial runs and niche production, we have the flexibility and responsiveness to sharpen, optimize and maximize your project.
Aseptic fill finish: Exceptional by design
Exceptional by design informs every aspect of our approach, allowing us to better service your needs through:
Quality
Benefit from our unwavering commitment to quality, including Annex 1 compliance and DEA Class II-V controlled substance approvals, ensuring your product meets the highest standards.
Scale
Access cGMP space rapidly for projects of any scale, from small clinical batches to large commercial production volumes and niche projects.
Automation
Our strategic implementation of advanced automation enhances engineering controls and optimizes your production process, delivering tangible value and increased efficiency.
Efficiency
Leverage our state-of-the-art technology and unmatched expertise to maintain efficient production timelines and maximize your product's success.
Beyond fill finish: Delivering exceptional value
Our aseptic fill finish capabilities extend beyond technical expertise. We optimize your entire production process, minimizing risk and maximizing efficiency through:
Our integrated approach to sterile injectables, spanning formulation through final packaging within our St. Louis facilities, streamlines your supply chain, reduces cycle times, and minimizes environmental impact.
With over half a century of experience as a leader in sterile fill finish, we strategically leverage technology at our Bridgeton facility to ensure unparalleled efficiency and compliance, tailoring each process to your precise needs.
As one of the few facilities globally to achieve complete Annex 1 compliance, we utilize the latest isolator technology, including both traditional glove access and advanced gloveless/robotic options, ensuring the highest standards of sterility assurance.
Our automated pre-use post-sterilization integrity testing (PUPSIT) system, integrated into the filling machines, ensures rigorous process controls and minimizes downtime. Each suite operates independently, allowing for concurrent operations and streamlined changeovers to keep your production on schedule.
We leverage artificial intelligence (AI) to analyze processes, enhance operator safety and reduce risks. Our commitment to implementing the latest technology ensures optimal efficiency and the highest standards of patient safety.
Related CDMO solutions
From development to commercial manufacturing and beyond, our CDMO solutions are designed to help your product progress with purpose.
Development
Our expert team collaborates with you, leveraging a development-by-design approach to optimize drug formulations and innovative delivery devices.
Learn more
Manufacturing
Discover scalable manufacturing solutions, from clinical trial supplies to commercial production, and state-of-the-art manufacturing facilities.
Learn more
Analytical
Comprehensive analytical testing and characterization services to ensure the quality, safety and efficacy of your drug products.
Learn more
Regulatory
Leverage comprehensive support to confidently navigate the global regulatory landscape, ensuring compliance with FDA, EMA and other international standards.
Learn moreFill finish resources and insights
Explore our library of resources to learn more about our fill finish facilities, capabilities and expertise.
Full-service CDMO powerhouse capabilities
Kindeva Drug Delivery is your full-service CDMO powerhouse, delivering unrivaled expertise for your combination product. Explore our services for every stage of development across device & product development, clinical supply, and commercial supply. We provide unmatched expertise and support across pulmonary & nasal, injectable, and transdermal drug-delivery platforms.
Learn More
How CDMO quality systems affect your product
A CDMO’s quality management system (QMS) approach directly impacts the the products it produces. Download this article to explore Kindeva’s approach to quality and risk mitigation and learn how this philosophy enables on-time, in-full delivery of high-quality products.
Learn More
Predictive engineering & digital twinning in biotech
The biotechnology industry can harness advanced engineering techniques in the form of predictive engineering and digital twinning to advance drug delivery device development. Download this article to discover: What digital twinning is and how it works Applications of digital twinning in other industries How Kindeva has leveraged predictive engineering and digital twinning for drug development […]
Learn More
Tech transfer commercial manufacturing mindset
Technology transfer (tech transfer) moves product and process knowledge between teams or partners and acts as a crucial bridge between ideation and commercialization. Especially for complex products like sterile injectables, a smooth tech transfer process is essential. In this white paper, discover valuable strategies to embrace a commercial manufacturing mindset from day one. Download your […]
Learn More
Your leading global CDMO
See our range of CDMO services and learn how we can bring your therapy to the world. Our platform technologies span pulmonary & nasal, injectable, and transdermal delivery, with services for every stage of combination product development & manufacturing. Discover how you can combine forces with us.
Learn MoreLet’s transform tomorrow together
Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.